Ken Griffin
NVCT icon

Ken Griffin’s Nuvectis Pharma NVCT Stock Holding History

Ken Griffin’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$606K Buy
+78,425
New +$672K ﹤0.01% 8828
2025
Q2 		– Sell
-10,344
Closed -$93.8K – 14265
2025
Q1 		$101K Buy
+10,344
New +$74.5K ﹤0.01% 11445
2024
Q3 		– Sell
-14,937
Closed -$94.6K – 14919
2024
Q2 		$94.6K Buy
+14,937
New +$102K ﹤0.01% 10996
2023
Q3 		– Sell
-28,028
Closed -$448K – 14829
2023
Q2 		$448K Buy
+28,028
New +$447K ﹤0.01% 8189
2022
Q3 		– Sell
-35,069
Closed -$393K – 13288
2022
Q2 		$393K Buy
+35,069
New +$434K ﹤0.01% 9175

Other funds holding NVCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ken Griffin's NVCT Position: Q1 2026 in Review

Ken Griffin opened a new position in Nuvectis Pharma (NVCT) in Q1 2026: 78,425 shares worth $606K. The stake represents ﹤0.01% of the portfolio and ranks #8828 among its holdings. This is a return to the name: Ken Griffin previously reported a position in NVCT as recently as Q1 2025.

Ken Griffin first reported a position in NVCT in Q2 2022 and has held it in 5 quarters since. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

  • Ken Griffin held 78,425 shares of Nuvectis Pharma worth $606K as of Q1 2026.
  • Nuvectis Pharma was a new Ken Griffin position in Q1 2026.
  • Nuvectis Pharma made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #8828 holding.
  • Ken Griffin first reported a position in Nuvectis Pharma in Q2 2022 and has held it in 5 quarters since.
  • 62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.